Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01946139 · ClinicalTrials.gov registry record · NA

Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV

A NA study, sponsored by AIDS Malignancy Consortium.

Completed
Registry status
NA
Development phase
276
Enrollment target

NCT01946139 is a NA study that has completed, run by AIDS Malignancy Consortium. The registered enrollment target is 276 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01946139, a NA study, has completed, sponsored by AIDS Malignancy Consortium.

COMPLETED
Registry status
NA
Development phase
276 participants
Enrollment target

Study Summary

This clinical trial studies anal human papillomavirus (HPV) tests in screening for cell changes in the anus in patients with human immunodeficiency virus (HIV). Screening tests may help doctors find cancer cells early and plan better treatment for anal cancer. Completing multiple screening tests may help find the best method for detecting cell changes in the anus.

Interventions

  • OTHER laboratory biomarker analysis
  • OTHER questionnaire administration
  • PROCEDURE quality-of-life assessment
  • PROCEDURE comparison of screening methods

Trial Details

FieldValue
Enrollment Target 276 participants
Start Date 2013-12-04
Est. Completion 2018-10-31
Phase NA

Sponsor

AIDS Malignancy Consortium

45 total trials

What the Registry Record Tells You About NCT01946139

The ClinicalTrials.gov registry entry for NCT01946139 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 276 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AIDS Malignancy Consortium, which has 45 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which laboratory biomarker analysis is the first listed.

NCT01946139 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01946139 about?

NCT01946139 is a clinical study titled "Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV". This clinical trial studies anal human papillomavirus (HPV) tests in screening for cell changes in the anus in patients with human immunodeficiency virus (HIV). Screening tests may help doctors find cancer cells early and plan better treatment for anal cancer. Completing multiple screening tests may...

What is the current status of trial NCT01946139?

This trial is currently completed. It is a NA study. The enrollment target is 276 participants. The study started on 2013-12-04. Estimated completion is 2018-10-31.

What interventions are being tested in trial NCT01946139?

The interventions under investigation include: laboratory biomarker analysis (OTHER), questionnaire administration (OTHER), quality-of-life assessment (PROCEDURE), comparison of screening methods (PROCEDURE).

Who is sponsoring clinical trial NCT01946139?

This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.